Search Results - Claire L. Langrish
- Showing 1 - 1 results of 1
-
1
Phase 1 clinical trial evaluating safety, exposure and pharmacodynamics of BTK inhibitor tolebrutinib (PRN2246, SAR442168) by Timothy D. Owens, Patrick F. Smith, Andrew Redfern, Yan Xing, Jin Shu, Dane E. Karr, Sonja Hartmann, Michelle R. Francesco, Claire L. Langrish, Philip A. Nunn, Steven G. Gourlay
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book